Insulin-like peptide 3 (INSL3) in men with congenital hypogonadotropic hypogonadism/Kallmann syndrome and effects of different modalities of hormonal treatment: a single-center study of 281 patients (Q34385778)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Insulin-like peptide 3 (INSL3) in men with congenital hypogonadotropic hypogonadism/Kallmann syndrome and effects of different modalities of hormonal treatment: a single-center study of 281 patients |
scientific article |
Statements
1 reference
Insulin-like peptide 3 (INSL3) in men with congenital hypogonadotropic hypogonadism/Kallmann syndrome and effects of different modalities of hormonal treatment: a single-center study of 281 patients (English)
1 reference
Sylvie Brailly-Tabard
1 reference
Luigi Maione
1 reference
Sylvie Salenave
1 reference
Julie Sarfati
1 reference
Claire Bouvattier
1 reference
Philippe Chanson
1 reference
Jacques Young
1 reference
Hélène Bry-Gauillard
1 reference
Hélène Affres
1 reference
Brigitte Delemer
1 reference
Yves Le Bouc
1 reference
15 November 2013
1 reference
1 reference
Identifiers
1 reference